Work

Survival and signals of response in advanced sarcoma patients enrolled on phase 1 trials in the era of precision oncology and novel immunotherapies.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.11063

Authors: Shiraj Sen, Kenneth R. Hess, David S. Hong, Gerald Steven Falchook, Roberto Pestana, Filip Janku, Aung Naing, Robert S. Benjamin, Shreyaskumar Patel, Funda Meric-Bernstam, Vivek Subbiah

Institutions: The University of Texas MD Anderson Cancer Center, Dow Chemical (Brasil)

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2962041394

Cites:

Cited by:

Related to: 10